Nectero Medical Receives FDA Clearance of IND Application to Initiate Phase II/III Clinical Trial of Nectero EAST® System for Treatment of Small- to Mid-Sized Abdominal Aortic Aneurysms

/PRNewswire/ -- Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease and improve patients' lives,...

Related Keywords

United States ,Americans ,Jack Springer ,Kaitlin Gallagher ,Bryan Ziegler ,Dan Clair ,Vanderbilt University Medical Center ,Nectero Medical Inc ,Berry Company Public Relations ,Department Of Vascular Surgery ,Drug Administration ,Investigational New Drug ,Chief Executive Officer ,Vascular Surgery ,Co Principal Investigator ,Nectero Medical ,Nc ,